Yakov Rotshteyn

Comparison of alamar blue and MTT assays for high through-put screening

Roslida Abd Hamid, Yakov Rotshteyn, Leyana Rabadi et al. · Toxicology in Vitro · 2004 · 560 citations

Mtt Assays, Medicine, Bioanalysis +10

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Kenneth J. Valenzano, Laykea Tafesse, Gary Lee et al. · Neuropharmacology · 2005 · 282 citations

Cannabis Use, Molecular Pharmacology, Pain Research +12

N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties

Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 249 citations · Full text

Antiviral Activity of Single‐Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV‐Infected Adults

Jeffrey M. Jacobson, Michael S. Saag, Melanie Thompson et al. · The Journal of Infectious Diseases · 2008 · 112 citations · Full text

Anti–HIV‐1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody

Jeffrey M. Jacobson, Melanie Thompson, Jacob Lalezari et al. · The Journal of Infectious Diseases · 2010 · 96 citations · Full text